DHR closes its $9.9B Masimo acquisition, adding AI-enabled patient-monitoring and sensor technologies to expand diagnostics ...

Danaher Corporation (NYSE: DHR), a global science and technology innovator, announced today that it has completed the acquisition ...

This regulatory milestone follows news from earlier this year, when the company announced positive verification study results ...

It's safe to assume at this point that the next generation of Apple Watches might not look dramatically different on the outside, but a fresh rumour suggests one of the wearable’s most controversial ...

Masimo Corporation (Nasdaq: MASI) (“Masimo”), a leading global innovator in patient monitoring, today announced that its stockholders voted in favor of the proposal to adopt the previously announced ...

The SET pulse oximetry technology used with a neonate. [Image courtesy of Masimo] Masimo (Nasdaq:MASI) today announced new study findings supporting the use of its SET pulse oximetry in critically ill ...

Apple can keep selling Apple Watches with its redesigned blood oxygen feature in the US after the ITC declined to revive Masimo’s ban. Apple has secured a significant victory in its years-long dispute ...

Apple has been embroiled in a six-year legal battle over one of its Apple Watch health apps. The end may finally be in sight, and here's what Apple has to say about it. Anna Gragert Senior Editor, ...

What just happened? Apple's latest Apple Watch redesign has cleared a key hurdle at a US trade agency, easing one immediate threat to its wearable roadmap while leaving a broader, high-stakes patent ...

A US appeals court has found in favor of Masimo in its fight against Apple over pulse oximetry patents, but in the court that matters, a ruling makes it clear that there won't be another ban on the ...